S&P Global upgrades HealthEquity rating on strong performance
Covered in this story
What has happened since
- S&P Global is up 7.1% since this was published, 26 days ago.
- Healthequity Inc is up 5.4% since this was published, 26 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on S&P Global
- Jefferies: $425 → $490 by Oct 2027 · Buy via Investing.com
- Baird: $432 → $513 by Sep 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $SPGI yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on S&P Global →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.